A nationwide screening program from the iStopMM study performed in Iceland to detect smoldering multiple myeloma reported a prevalence of 0.5% in individuals over 40 years of age, with increasing risks with age and in males.
- Sigrún Thorsteinsdóttir
- Gauti K. Gíslason
- Sigurður Y. Kristinsson